Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer)

被引：3
|
作者：
Zengarini, C. [1 ,2 ]
Misciali, C. [1 ,2 ]
Ferrari, T. [1 ,2 ]
Dika, E. [1 ,2 ]
La Placa, M. [1 ,2 ]
Piraccini, B. M. [1 ,2 ]
Baraldi, C. [1 ,2 ]
机构：
[1] IRCCS Azienda Osped Univ Bologna, Dermatol Unit, Bologna, Italy
[2] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2022年 / 36卷 / 08期
关键词：
D O I：
10.1111/jdv.18154
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E622 / E623
页数：2
相关论文
共 50 条
  • [1] Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2
    Lauro, Wanda
    Cillo, Francesco
    Nastro, Francesca
    Fabbrocini, Gabriella
    Marasca, Claudio
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 364 - 365
  • [2] DIFFERENT IMMUNOGENICITY OF PREVIOUS SARS-COV-2 INFECTION OR COMIRNATY VACCINE (BNT162B2, BIONTECH/PFIZER) IN HAEMODIALYSIS PATIENTS
    Gembillo, Guido
    Giuffrida, Alfio Edoardo
    Labbozzetta, Vincenzo
    Siligato, Rossella
    Spallino, Eugenia
    Sposito, Giovanna
    Ferlazzo, Guido
    Cuzzola, Felicia
    Lipari, Antonella
    Calabrese, Vincenzo
    Santoro, Domenico
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I663 - I664
  • [3] A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine
    Martora, Fabrizio
    Fabbrocini, Gabriella
    Picone, Vincenzo
    DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [4] Subacute thyroiditis after SARS-CoV-2 BNT162b2 vaccine in a multiple myeloma patient
    Alkis, Nihan
    Baysal, Mehmet
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [5] Herpes zoster ophthalmicus in two women after Pfizer-BioNTech (BNT162b2) vaccine
    Bernardini, Nicoletta
    Skroza, Nevena
    Mambrin, Alessandra
    Proietti, Ilaria
    Marchesiello, Anna
    Marraffa, Federica
    Rossi, Giovanni
    Volpe, Salvatore
    Tolino, Ersilia
    Potenza, Concetta
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 817 - 818
  • [6] Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty®])
    Ando, Masaru
    Satonaga, Yoshio
    Takaki, Ryuichiro
    Yabe, Michitoshi
    Kan, Takamasa
    Omote, Erika
    Yamasaki, Toru
    Komiya, Kosaku
    Hiramatsu, Kazufumi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 187 - 189
  • [7] SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
    Falsey, Ann R.
    Frenck, Robert W., Jr.
    Walsh, Edward E.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Bailey, Ruth
    Swanson, Kena A.
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren
    Cooper, David
    Zou, Jing
    Xie, Xuping
    Xia, Hongjie
    Tuereci, Ozlem
    Lagkadinou, Eleni
    Tompkins, Kristin R.
    Shi, Pei-Yong
    Jansen, Kathrin U.
    Sahin, Ugur
    Dormitzer, Philip R.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1627 - 1629
  • [8] BNT162b2 Vaccine against SARS-CoV-2 effective in Children
    Meinrenken, Susanne
    PNEUMOLOGIE, 2022, 76 (03):
  • [9] Skin reaction following SARS-CoV-2 vaccine BNT162b2
    Russo, Filomena
    Santi, Francesco
    Sirchio, Azzurra
    Lazzeri, Laura
    De Piano, Ernesto
    Taddeucci, Paolo
    Rubegni, Pietro
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 360 - 361
  • [10] Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
    Anastasi, Emanuela
    Marziali, Marco
    Preziosi, Adele
    Berardelli, Elena
    Losardo, Anna Annunziata
    Ribersani, Michela
    Pugliese, Pellegrina
    Farina, Antonella
    Mancini, Patrizia
    Angeloni, Antonio
    MICROBES AND INFECTION, 2022, 24 (6-7)
12345